Because of IDSC extensive drug discovery, drug development, and therapeutic area expertise, virtual, small, medium, and large biotech companies; large pharmaceutical companies, research foundations and academic institutions come to IDSC to help them get from early discovery through phase III clinical trials. This is a partial list of IDSC's clients who have given permission to publish their names:
![]() |
|
|
|
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
| AKI |
|
|
|